Oil-Dri Announces Record Results for the First Quarter of Fiscal Year 2025

CHICAGO, Dec. 09, 2024 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, today announced results for its first quarter of fiscal year 2025.

  First Quarter
(in thousands, except per share amounts) Ended October 31,
  2024 2023 Change
Consolidated Results      
Net Sales $ 127,945 $ 111,438 15  %
Operating Income (Including Unallocated Corporate Expenses) $ 21,190 $ 13,156 61  %
Net Income $ 16,376 $ 10,742 52  %
EBITDA † $ 26,167 $ 17,384 51  %
Diluted EPS – Common $       2.25 $       1.50 50  %
Business to Business      
Net Sales $ 48,415 $ 39,161 24  %
Segment Operating Income $ 17,110 $ 11,123 54  %
Retail and Wholesale      
Net Sales $ 79,530 $ 72,277 10  %
Segment Operating Income $ 13,377 $ 11,331 18  %

† Please refer to Reconciliation of Non-GAAP Financial Measures below for a reconciliation of Non-GAAP items to the comparable GAAP measures.
 

Daniel S. Jaffee, President and Chief Executive Officer, stated, “I am happy to report that our fiscal year 2025 is off to a very positive start as we have once again achieved record results for consolidated net sales, gross profit, and net income in the first quarter.  We also delivered a 400-basis point year-over-year expansion in our gross margins, propelling our margins to 32%.   Our strong performance was driven by increased volumes, a favorable product mix, and improved operational efficiencies.  Solid execution of our growth strategies to establish a foothold in the growing renewable diesel and crystal cat litter markets helped us achieve this success.  Looking ahead, we believe we are well positioned to continue this upward trajectory.” 

Consolidated Results                                                                                                                
Consolidated net sales for the first quarter of fiscal 2025 reached a historic high of $127.9 million, or a 15% increase over the same period in the prior year.  This marks the 14th consecutive quarter of year-over-year sales growth.  Revenue increases were primarily driven by higher volumes across both operating segments, with significant sales gains generated from fluids purification, crystal cat litter, and co-packaged coarse litter products. Our recently acquired subsidiary, Ultra Pet Company, Inc. (“Ultra Pet”), delivered net sales of $6.0 million, or 5% of the total consolidated net sales increase over the prior year.  Organic growth from Oil-Dri’s other products drove the remaining increase in the Company’s topline.

Consolidated gross profit of $40.8 million, a record quarterly high, was achieved during the first three months of fiscal year 2025, representing a 32% gain over the prior year.  Gross margins expanded to 32% in the current year from 28% in the first quarter of fiscal year 2024.  Oil-Dri’s efforts to grow volume, improve product mix, and enhance operating efficiencies proved successful during the quarter.  This marks the ninth consecutive quarter of year-over-year gross margin expansion.  During the three months ended October 31, 2024, domestic cost of goods per ton remained flat compared to the prior year. 

Selling, general and administrative expenses (“SG&A”) were $19.6 million during the first quarter of fiscal 2025 compared to $17.8 million for the same period last year.  This $1.8 million, or 10%, increase reflects higher compensation costs and a preliminary foreign value-added tax assessment, in addition to other operating segment costs.   

In the first quarter of fiscal year 2025, consolidated operating income increased to $21.2 million, or by 61%, compared to the first quarter of fiscal year 2024.  Higher sales volumes combined with improved product mix offset elevated SG&A costs.

Total other expense, net was $1.0 million for the three months ended October 31, 2024, compared to $300,000 in the same period last year.  This increase was mainly due to interest expense on the debt assumed for the Ultra Pet acquisition, along with an additional reserve for the capacity modification project at the Company’s sole landfill located in Georgia. The modification work is expected to be completed during fiscal year 2025.

Consolidated net income reached a record $16.4 million in the first quarter of fiscal 2025 from $10.7 million in the same period in fiscal 2024, reflecting a 52% improvement over the prior year.

Cash and cash equivalents for the three month period ending October 31, 2024, totaled $12.5 million compared to $23.5 million at the end of fiscal year 2024.  During the first quarter of fiscal 2025, Oil-Dri continued its significant investment in manufacturing infrastructure improvements.  In addition, the Company paid down $5.0 million of the $10.0 million revolving credit facility that was used to partially fund the acquisition of Ultra Pet.  Other significant uses of cash include the payment of dividends and the purchase of treasury shares that were surrendered by teammates to pay taxes related to the vesting of restricted stock awards.

Product Group Review
The Business to Business Products (“B2B”) Group’s  first quarter of fiscal year 2025 revenues were a record $48.4 million, or 24% greater than the prior year, primarily driven by an increase in volume and, to a lesser extent, by higher prices.  Elevated sales from fluids purification and agricultural products offset slight sales declines in the animal health business.  During the first quarter of fiscal 2025, revenues from fluids purification products reached an all-time high of  $30.1 million, or an 37% increase over the prior year.  The Company experienced increased demand of its Metal X and Metal Z products as a result of recently established renewable diesel plants within North America.  Sales of fluids purification products in EMEA1, Latin America, and Asia also increased during the three month period ended October 31, 2024, compared to the same period last year.  The agricultural products business achieved record quarterly net sales of $11.6 million, or a 12% increase over the prior year.  This growth was mainly fueled by higher demand from key customers who resumed typical purchasing patterns after working through inventory surpluses, as well as by elevated prices.  Amlan, the Company’s animal health business, generated $6.2 million in sales, or a 3% decline from the prior year. The decrease was primarily concentrated in Asia due to the sell-off of existing inventory in China that occurred in the first quarter of fiscal year 2024 as part of the transition to a master distributor.  However, double-digit topline growth was achieved within Latin America and North America where increased demand, in conjunction with elevated prices, helped drive sales improvement.

During the first quarter of fiscal year 2025, SG&A costs within the B2B Products Group increased by $700,000 or 20%, compared to the same period last year.  This was mainly driven by a preliminary foreign value-added tax assessment and higher research and development costs.

Operating income for the B2B Products Group was $17.1 million in the first quarter of fiscal year 2025 compared to $11.1 million in the same period of fiscal year 2024, reflecting a 54% increase.  This growth can be attributed to higher sales and a favorable product mix, partially offset by increased SG&A expenses.

The Retail and Wholesale (“R&W”) Products Group’s first quarter revenues reached an all-time high of $79.5 million, a 10% increase over the prior year.  The acquisition of Ultra Pet contributed 8% of the total R&W sales growth, and the remaining 2% can be attributed to organic topline growth from increased demand for other products within the operating segment. During the first quarter of fiscal 2025, the Company increased distribution of its Cat’s Pride and Ultra crystal litter products and is beginning to realize synergies related to the acquisition.  Total domestic clay-based cat litter sales, excluding the Company’s co-packaged coarse cat litter business, were $53.8 million, or 2% lower than the prior year.  Conversely, revenues of co-packaged coarse cat litter increased by $2.1 million, or 78%, compared to last year due to higher demand.  In the first quarter of fiscal year 2024, a cyberattack disrupted a key customer’s ability to place and receive orders, which negatively impacted sales of Oil-Dri’s co-packaged coarse litter.  However, the cyber event boosted sales of the Company’s branded and private label coarse items and is currently influencing year-over-year comparisons for both domestic clay and co-packaged litter products.  Although total domestic clay litter revenues declined, Oil-Dri continued to experience topline growth of its EPA-approved Cat’s Pride Antibacterial Clumping Litter, which is currently sold at large brick and mortar and e-commerce retailers.  In addition, new distribution of other clay litter products and accessories was achieved at both new and existing customers.  Domestic industrial and sports product revenues were $11.0 million in the first quarter of fiscal 2025, or 4% higher than the same period in the prior year, driven by increased demand.  The Company’s Canadian subsidiary experienced sales declines as a result of softer revenues from cat litter, partially offset by sales growth from industrial floor absorbent products.

During the first quarter of fiscal 2025, SG&A expenses within the R&W Products Group increased by $1.0 million, or 21% over the prior year.  This increase was primarily driven by higher compensation costs, a significant credit reserve for several customer bankruptcies, acquisition-related amortization of intangible assets, and increased research and development costs.  These higher expenses were partially offset by lower advertising costs.  Oil-Dri expects advertising expenditures for the full fiscal year 2025 to be lower than fiscal year 2024. 

Operating income for the R&W Products Group reached $13.4 million in the first quarter of fiscal year 2025 compared to $11.3 million in the prior year, reflecting an 18% increase.  This growth can be attributed to higher sales volumes, including the incremental business from the Ultra Pet acquisition, partially offset by elevated SG&A expenses.

The Company will host its first quarter of fiscal year 2025 earnings discussion and its 2024 Annual Meeting of Stockholders virtually via a live webcast on Wednesday, December 11, 2024 at 9:30 a.m. Central Time. Participation details are available on the Company’s website’s Events page.

1EMEA is the region including Europe, the Middle East, and Africa.
“Oil-Dri”, “Cat’s Pride”, “Metal X”, “Metal Z”, “Amlan”, and “Ultra” are registered trademarks of Oil-Dri Corporation of America and its subsidiaries. 

About Oil-Dri Corporation of America
Oil-Dri Corporation of America is a leading manufacturer and supplier of specialty sorbent products for the pet care, animal health and nutrition, fluids purification, agricultural ingredients, sports field, industrial and automotive markets.  Oil-Dri is vertically integrated which enables the Company to efficiently oversee every step of the process from research and development to supply chain to marketing and sales. With over 80 years of experience, the Company continues to fulfill its mission to Create Value from Sorbent Minerals

Forward-Looking Statements
Certain statements in this press release may contain forward-looking statements, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that are based on our current expectations, estimates, forecasts and projections about our future performance, our business, our beliefs and our management’s assumptions. In addition, we, or others on our behalf, may make forward-looking statements in other press releases or written statements, or in our communications and discussions with investors and analysts in the normal course of business through meetings, webcasts, phone calls and conference calls. Forward-looking statements can be identified by words such as “expect,” “outlook,” “forecast,” “would,” “could,” “should,” “project,” “intend,” “plan,” “continue,” “believe,” “seek,” “estimate,” “anticipate,” “may,” “assume,” “potential,” “strive,” and similar references to future periods.

Such statements are subject to certain risks, uncertainties and assumptions that could cause actual results to differ materially, including, but not limited to, those described in Item 1A, “Risk Factors” of our Quarterly Report on Form 10-Q for the quarter ended October 31, 2024 and our most recent Annual Report on Form 10-K and from time to time in our other filings with the Securities and Exchange Commission. Should one or more of these or other risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, intended, expected, believed, estimated, projected, planned or otherwise expressed in any forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Except to the extent required by law, we do not have any intention or obligation to update publicly any forward-looking statements after the distribution of this press release, whether as a result of new information, future events, changes in assumptions, or otherwise.

Non-GAAP Financial Measures
To supplement our consolidated financial statements prepared in accordance with generally accepted accounting principles (“GAAP”), we provide certain non-GAAP financial measures in this press release as supplemental financial metrics. In particular, EBITDA is a non-GAAP financial measure provided herein. We provide a reconciliation of this non-GAAP financial measure to the most directly comparable GAAP financial measure below.

The non-GAAP financial measures we use may not be the same or calculated in the same manner as those used and calculated by other companies. Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as a substitute for our financial results prepared and reported in accordance with GAAP. We believe that certain non-GAAP measures may be helpful to investors and others in understanding and evaluating our operating results, and we urge investors to review the reconciliation of non-GAAP financial measures to the comparable GAAP financial measures included in this release, and not to rely on any single financial measure to evaluate our business.

Contact:
Leslie A. Garber
Director of Investor Relations
Oil-Dri Corporation of America
[email protected] 
(312) 321-1515

CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
                 
    Three Months Ended October 31,
    2024   % of Sales   2023   % of Sales
Net Sales   $ 127,945     100.0  %   $ 111,438     100.0  %
Cost of Goods Sold     (87,165 )   (68.1 )%     (80,447 )   (72.2 )%
Gross Profit     40,780     31.9  %     30,991     27.8  %
Selling, General and Administrative Expenses    (19,590 )   (15.3 )%     (17,835 )   (16.0 )%
Operating Income     21,190     16.6  %     13,156     11.8  %
Other Expense, Net     (988 )   (0.8 )%     (326 )   (0.3 )%
Income Before Income Taxes     20,202     15.8  %     12,830     11.5  %
Income Taxes Expense     (3,826 )   (3.0 )%     (2,088 )   (1.9 )%
Net Income     16,376     12.8  %     10,742     9.6  %
                 
Net Income Per Share:          Basic Common $ 2.43         $ 1.61      
                                        Basic Class B $ 1.82         $ 1.21      
                                        Diluted Common $ 2.25         $ 1.50      
                                             Diluted Class B $ 1.82         $ 1.21      
Avg Shares Outstanding:      Basic Common   4,922           4,827      
                                        Basic Class B   1,984           1,967      
                                                 Diluted Common   6,906           6,794      
                                        Diluted Class B   1,984           1,967      
CONSOLIDATED BALANCE SHEETS      
(in thousands, except per share amounts)      
  As of October 31,   As of July 31,
  2024   2024
Current Assets      
Cash and Cash Equivalents $                    12,506   $              23,481
Accounts Receivable, Net                         70,544                     62,171
Inventories, Net                         56,025                     54,236
Prepaid Expenses and Other Assets                           5,040                       7,270
Total Current Assets                       144,115                   147,158
Property, Plant and Equipment, Net                       137,947                   137,796
Other Assets                         68,109                     69,651
Total Assets $                  350,171   $            354,605
       
Current Liabilities      
Current Maturities of Notes Payable $                       1,000   $                 1,000
Accounts Payable                         13,824                     15,009
Dividends Payable                           2,098                       2,096
Other Current Liabilities                         37,919                     48,572
Total Current Liabilities                         54,841                     66,677
Noncurrent Liabilities      
Notes Payable                         44,777                     49,774
Other Noncurrent Liabilities                         26,561                     27,566
Total Noncurrent Liabilities                         71,338                     77,340
Stockholders’ Equity                       223,992                   210,588
Total Liabilities and Stockholders’ Equity $                  350,171   $            354,605
       
Book Value Per Share Outstanding $                       32.43   $                 30.69
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
  For the Three Months Ended
  October 31,
  2024   2023
CASH FLOWS FROM OPERATING ACTIVITIES      
Net Income $              16,376     $              10,742  
Adjustments to reconcile net income to net cash      
provided by operating activities:      
Depreciation and Amortization                     5,381                         4,368  
Increase in Accounts Receivable                   (9,020 )                     (1,487 )
Increase in Inventories                   (2,033 )                     (1,374 )
Decrease in Prepaid Expenses                     2,228                            154  
Increase (Decrease) in Accounts Payable                     1,889                       (1,289 )
Decrease in Accrued Expenses                   (6,117 )                     (4,365 )
Other                     2,215                         1,815  
Total Adjustments                   (5,457 )                     (2,178 )
Net Cash Provided by Operating Activities                   10,919                         8,564  
       
CASH FLOWS FROM INVESTING ACTIVITIES      
Capital Expenditures                 (12,817 )                     (8,064 )
Net Cash Used in Investing Activities                 (12,817 )                     (8,064 )
       
CASH FLOWS FROM FINANCING ACTIVITIES      
Principal Payments on Notes Payable                   (5,000 )                             —  
Dividends Paid                   (2,096 )                     (1,927 )
Purchases of Treasury Stock                   (1,984 )                        (872 )
Net Cash Used In Financing Activities                   (9,080 )                     (2,799 )
       
Effect of exchange rate changes on Cash and Cash Equivalents                             3                            124  
       
Net Decrease in Cash and Cash Equivalents                 (10,975 )                     (2,175 )
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period                   24,481                       31,754  
Cash, Cash Equivalents and Restricted Cash, End of Period $              13,506     $              29,579  
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES    
(in thousands)
  First Quarter
  Ended October 31,
  2024   2023
GAAP: Net Income $ 16,376     $ 10,742  
Depreciation and Amortization $ 5,381     $ 4,368  
Interest Expense $ 734     $ 361  
Interest Income $ (150 )   $ (175 )
Income Tax Expense $ 3,826     $ 2,088  
EBITDA $ 26,167     $ 17,384  
               

This press release was published by a CLEAR® Verified individual.


Bay Street News